The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Shah Sujal since year 2005.
The trader's CIK number is 1588861.
At the time of this reporting, Shah Sujal is the Interim President & CEO of Cymabay Therapeutics, Inc. .
(stock ticker symbol NONE).
See this page for all insider trading activities at Cymabay Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-07-20||CBAY||Cymabay Therapeutics, Inc.||Buy||10,000||7.31||73,140|
|2016-04-05||CBAY||Cymabay Therapeutics, Inc.||Buy||33,000||1.39||45,870|
|2016-04-04||CBAY||Cymabay Therapeutics, Inc.||Buy||22,000||1.39||30,579|
|2015-05-18||CBAY||Cymabay Therapeutics, Inc.||Buy||10,000||3.40||34,000|
|2014-09-16||NONE||Cymabay Therapeutics, Inc.||Buy||10,000||7.44||74,400|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shah Sujal (Interim President & CEO of Cymabay Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.